[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health":3,"$f30wq5yivbnmuj":14},{"ok":4,"db":5,"lastOrangeBookRun":6,"lastDrugsFdaRun":9,"lastAlertsRun":12,"stale":13},true,"ok",{"status":5,"startedAt":7,"finishedAt":8,"lastOkAt":8},"2026-10-26T06:44:32.239Z","2026-10-26T06:44:53.640Z",{"status":5,"startedAt":10,"finishedAt":11,"lastOkAt":11},"2026-10-26T06:45:02.648Z","2026-10-26T06:45:13.189Z",null,false,{"tradeName":15,"ingredient":16,"applicant":17,"applicantSlug":18,"applNos":19,"loe":12,"latestLoe":12,"basis":21,"carveOutPossible":13,"openStrengths":22,"headlineStrengths":22,"headlineFallback":13,"approvalsBeforeLoe":23,"products":24,"patents":48,"exclusivities":49,"paragraphIv":50,"catalysts":52},"WELLBUTRIN SR","BUPROPION HYDROCHLORIDE","GLAXOSMITHKLINE","glaxosmithkline",[20],"020358","none",3,0,[25,33,39,43],{"key":26,"applNo":20,"productNo":27,"dosageForm":28,"route":29,"strength":30,"approvalDate":31,"rld":13,"teCode":12,"type":32,"loe":12,"basis":21,"carveOutPossible":13},"020358-001","001","TABLET, EXTENDED RELEASE","ORAL","50MG","1996-10-04","DISCN",{"key":34,"applNo":20,"productNo":35,"dosageForm":28,"route":29,"strength":36,"approvalDate":31,"rld":4,"teCode":37,"type":38,"loe":12,"basis":21,"carveOutPossible":13},"020358-002","002","100MG","AB1","RX",{"key":40,"applNo":20,"productNo":41,"dosageForm":28,"route":29,"strength":42,"approvalDate":31,"rld":4,"teCode":37,"type":38,"loe":12,"basis":21,"carveOutPossible":13},"020358-003","003","150MG",{"key":44,"applNo":20,"productNo":45,"dosageForm":28,"route":29,"strength":46,"approvalDate":47,"rld":4,"teCode":37,"type":38,"loe":12,"basis":21,"carveOutPossible":13},"020358-004","004","200MG","2002-06-14",[],[],{"asOf":12,"firstFiled":12,"entries":51},[],[]]